EUVIMEDOpdag EUVIMED
VergleichsstudieOpen access · CC BY 4.0

A Comparison of a Drug Coated Balloon With Drug Eluting Stent Strategy for Treating Coronary Bifurcation Lesions

Natasha Corballis iD, Ioannis Merinopoulos iD, U Bhalraam, Tharusha Gunawardena iD, Vasiliki Tsampasian, Rajkumar Natarajan, Upul Wickramarachchi, Mohamed Mohamed, Allan Clark, Mamas A Mamas iD, Vassilios S Vassiliou, Simon Eccleshall and 1 more

Catheterization and Cardiovascular Interventions · 2026-01 · 107 (1) · 3-14

DOI: 10.1002/ccd.70273 ↗

At a glance

Vergleichsstudie in Catheterization and Cardiovascular Interventions, published online on 2025-10-28. Written by Natasha Corballis and 12 co-authors. Institution: Department of Medicine, University of East Anglia, Norwich, UK. Major MEDLINE topics: Drug-Eluting Stents, Coronary Artery Disease, Angioplasty, Balloon, Coronary, Cardiac Catheters. Cited 2 times so far (Crossref); 41 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

The treatment of coronary bifurcation lesions (CBL) remains complex and associated with a higher rate of long‐term adverse cardiovascular events due to anatomical and procedural complexity.

Aims

We compared procedural outcomes between a drug coated balloon (DCB) only approach and a 2nd generation drug eluting stent (DES) for treating de novo CBLs.

Methods

We retrospectively identified all patients with CBL treated with either a DCB only or DES only strategy, including all coronary bifurcations and compared a bifurcation‐oriented composite endpoint (BOCE) of cardiovascular death, target bifurcation‐related myocardial infarction (TB‐MI), and clinically driven target bifurcation revascularization (TBR) using nationally obtained clinical outcome measures from 2015 to 2019. A propensity score matched analysis was undertaken.

Results

Of 2113 patients, 1030 patients were treated with a DCB and 1083 with a DES. There was higher lesion complexity in the DCB group, and propensity score‐matched analysis was utilized. This included a total of 2052 patients (1026 in each arm). The median age was 68 (59−75), and all clinical presentations were included. The median follow‐up time was 3.6 (2.5−4.8) years with 501 (48.8%) patients having follow‐up available at 5 years. Propensity matched analysis showed a significant increase in events (14.0% vs. 9.9% respectively) (HR: 1.39 [1.08−1.79], p = 0.01) when using DES compared to DCB, driven predominantly by an increase in TBR (8.9% vs. 5.0%) (HR: 1.79 [1.27−2.50], p ≤ 0.001) and TB‐MI (3.0% vs. 1.6%) (HR: 1.92 [1.05−3.57], p 0.03).

Conclusions

The use of DCB‐only in a coronary bifurcation is a safe alternative in treating CBL, within the limitations of a retrospective single center analysis. An appropriately designed RCT is now required.

Subjects

MeSH terms (MEDLINE)

Drug-Eluting StentsCoronary Artery DiseaseAngioplasty, Balloon, CoronaryCardiac CathetersCoated Materials, BiocompatibleHumansRetrospective StudiesMaleFemaleAgedMiddle AgedTreatment OutcomeTime FactorsProsthesis DesignRisk FactorsDatabases, FactualRisk Assessment

Author keywords

PCIcomplex PCIcoronary bifurcation lesionsdrug coated balloons

Substances

Coated Materials, Biocompatible

Authors and institutions

  • Department of Medicine, University of East Anglia, Norwich, UK.
  • Department of Cardiology, Norfolk and Norwich University Hospital, Norwich, UK.
  • Institute of Health Informatics, University College London, London, UK.
  • Keele Cardiovascular Research Group, Centre for Prognosis Research, Institute for Primary Care and Health Sciences, Keele University, Keele, UK.

ORCID profiles: Natasha Corballis, Ioannis Merinopoulos, Tharusha Gunawardena, Mamas A Mamas

Cite

APA

Corballis, N., Merinopoulos, I., Bhalraam, U., Gunawardena, T., Tsampasian, V., Natarajan, R., Wickramarachchi, U., Mohamed, M., Clark, A., Mamas, M. A., Vassiliou, V. S., Eccleshall, S., & SPARTAN‐Norfolk Consortium (2026). A Comparison of a Drug Coated Balloon With Drug Eluting Stent Strategy for Treating Coronary Bifurcation Lesions. Catheterization and Cardiovascular Interventions, 107(1), 3-14. https://doi.org/10.1002/ccd.70273

Vancouver

Corballis N, Merinopoulos I, Bhalraam U, Gunawardena T, Tsampasian V, Natarajan R, et al. A Comparison of a Drug Coated Balloon With Drug Eluting Stent Strategy for Treating Coronary Bifurcation Lesions. Catheterization and Cardiovascular Interventions. 2026;107(1):3-14. doi:10.1002/ccd.70273

BibTeX
@article{Corballis2026,
  author = {Corballis, Natasha and Merinopoulos, Ioannis and Bhalraam, U and Gunawardena, Tharusha and Tsampasian, Vasiliki and Natarajan, Rajkumar and Wickramarachchi, Upul and Mohamed, Mohamed and Clark, Allan and Mamas, Mamas A and Vassiliou, Vassilios S and Eccleshall, Simon and SPARTAN‐Norfolk Consortium, SPARTAN‐Norfolk Consortium},
  title = {A Comparison of a Drug Coated Balloon With Drug Eluting Stent Strategy for Treating Coronary Bifurcation Lesions},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2026},
  volume = {107},
  number = {1},
  pages = {3--14},
  doi = {10.1002/ccd.70273}
}
Start for free →